Leadership Bios

Dave Winwood, Ph.D., Chairman of the Board

Dr. David Winwood is Chief Executive Officer of the UAB Research Foundation. He has previously managed technology transfer activities at North Carolina State University and The Ohio State University. At NC State University he also managed the Centennial Campus Partnership Office, with responsibility for corporate and government partner recruitment. He holds B.Sc., M.Sc., and Ph.D. degrees in chemistry from the University of East Anglia (England), and a Master of Arts degree in liberal studies from NC State. In addition to university technology licensing experience, he has experience in business development and early stage drug development activities at companies in the Research Triangle Park area of North Carolina. He has served on several business and economic development boards in North Carolina and Ohio and as Second Vice President for the Association of University Research Parks. He serves on the Board of Directors of the Council on Govenmental Relations and is a member of the U.S. Council on Competitiveness’ Regional Innovation Initiative Expert Committee. He also serves on the Boards of Directors for the Birmingham Venture Club, Innovation Depot, the Biotechnology Association of Alabama and TechBirmingham.

Kathy Nugent, Ph.D., President

Dr. Kathy Nugent is a senior biotechnology executive with over 20 years of healthcare industry experience. Dr. Nugent currently serves as the director and assistant professor of the Masters of Biotechnology program at UAB (University of Alabama at Birmingham.)  Dr. Nugent specializes in providing senior counsel to companies focused on pharmaceutical discovery and development. Specifically, she provides strategic guidance in the areas of financial, scientific and regulatory communications, product launches and crisis management.

Dr. Nugent also serves as the current President of the Biotechnology Association of Alabama. In this role, Dr. Nugent interacts with state biotechnology companies, affiliated organizations, economic development allies, academia, and state government officials. Dr. Nugent was an adjunct professor at the City University of New York, Hunter College, Baruch College and Medgar Evers College.

Dr. Nugent earned her Ph.D. in biopsychology at the City University of New York and completed a post-doctoral fellowship in Pharmacology at the Weill-Cornell Medical College.

Art Tipton, Ph.D., Immediate Past Chairman

Cecil Bostany, Treasurer

Cecil Bostany joined Warren Averett as a Member in the Tax Division in 2002. He is a former partner with Ernst & Young and has over 32 years of experience working with privately-owned, venture-backed and publicly-held companies. He has extensive experience in mergers & acquisitions, due-diligence, transaction structuring and financing and is a taxation planning specialist.  Cecil serves clients in a variety of industries including technology, venture capital, manufacturing and automotive.

Steve Ceulmans, Secretary/Ex-Officio

Steven Ceulemans is the vice president of innovation and technology for the Birmingham Business Alliance. An expert in technology commercialization and Alabama’s first economic development professional solely dedicated to innovation and technology. Ceulemans’ focus at the BBA is on supporting the growth of the innovation-driven economy in the Birmingham region.

Before joining the BBA in September 2011, Steven served as the director of technology commercialization for the New Orleans BioInnovation Center, where he managed a number of technology-based economic development and venture creation programs aimed at growing technology startups in New Orleans, LA. He was responsible for the technology commercialization initiatives related to the South Louisiana Institute for Infectious Disease Research, the Louisiana Vaccine Center, and the Clinical and Translational Research, Education and Commercialization Project, all of which were funded through a partnership between Louisiana State University Health Sciences Center and Tulane University. Before that, Ceulemans worked in R&D and technology development roles for a number of organizations including Software AG, Tibotec (Johnson and Johnson), Procter and Gamble, and the Joint Research Centre (European Commission).

Ceulemans holds a master’s degree in international business from Vlekho Business School in Brussels, Belgium; a Master of Science degree in biochemistry and molecular biology from LSU Health Sciences Center in New Orleans; and a Bachelor of Science degree in chemistry from Artesis University College of Antwerp, Belgium.

He lives in Birmingham with his wife, Melissa, who is a resident in internal medicine at the University of Alabama at Birmingham.

Carter Wells,  Ex-Officio

Carter Wells is the Director of External Affairs at the HudsonAlpha Institute for Biotechnology, which has a three-fold mission of genomic research, economic development and educational outreach.  He is responsible for building the philanthropic programs that support the institute, interacting with leaders in various areas of government and establishing an environment conducive for a biotech economy.

Additionally, Mr. Wells serves as CEO of iCubate, Inc., a privately held molecular diagnostic company. iCubate is producing a system designed to provide accurate, rapid detection of multiple pathogens in a disposable cassette. He is responsible for providing the strategic vision for the company, raising capital and managing the team of chemists, engineers and biologists.

Mr. Wells currently serves on the executive committee of the Biotechnology Association of Alabama, as a board member of the Huntsville/Madison County Public Library, a trustee of The Nature Conservancy, a member of the Auburn University-Huntsville Research Council, a member of the Huntsville Hospital Development Council and a member of the Huntsville Rotary Club.

A political science graduate of Auburn University, Mr. Wells has worked in various government and political positions. Prior to joining HudsonAlpha, he served as Chief of Staff for former U.S. Congressman Bud Cramer.

Devon Laney, Ex-Officio

Devon Laney is the Chief Operating Officer of Innovation Depot, Inc., the high-tech/biotech business incubator located in downtown Birmingham and recipient of the 2011 Technology Incubator of the Year Award from the National Business Incubation Association. Prior to joining Innovation Depot, Devon worked on a broad range of marketing, I/T and strategic organizational projects with various Fortune 500 companies as an analyst with Accenture LLP in Atlanta. Previously, he worked on the development, redesign and launch of Energen Corporation’s intranet, and also served as the Entertainment Editor for nationally distributed Family Issues Magazine during its first 18 months of publication.
In the Birmingham community, Devon serves as President on the Board of the
Birmingham Venture Club, where he is the youngest member to ever serve and the only consecutive back-to-back President. Additionally, Devon serves on the Executive Committees of TechBirmingham and the Biotechnology Association of Alabama. He also serves on the Board of Operation New Birmingham’s Magic City Art Connection, The Alys Stephens Center Young Patrons Board and on the Birmingham Children’s Theatre Young Supporters Board. Devon is a member of the 2008 inaugural class of Leadership UAB and the 2010 Class of Leadership Birmingham. In 2009 Devon was selected as one of The Birmingham Business Journal’s “Top 40 Under 40”. He has spoken at conferences in the U.S. and internationally on entrepreneurial development and business incubation.
Mr. Laney has a Masters Degree in Business Administration and a Bachelors Degree in International Business, both from The University of Alabama. Devon also completed studies at the International Business School in Groningen, the Netherlands. He currently lives in the Crestwood neighborhood of Birmingham with his wife Meg and their three dogs. Devon also enjoys playing racquetball, coaching tee-ball, and playing music every chance he gets.

Daniel Daly, Ph.D., Ex-Officio

 Dr. Dan Daly received B.S. in Chemistry and Psychology from Florida State University, Tallahassee, FL. He went on to receive a Ph.D. in Physical-Organic Chemistry from the University of Florida inGainesville, Florida. He did two post-doctoral studies at The University of South Florida in Tampa, Florida and Oregon State University in Corvallis, Oregon in computer-assisted molecular design. Dr. Daly is currently the Director of the Alabama Institute for Manufacturing Excellence. He has 17 years experience in the fuel and lubricant businesses were he served as Technology and Business Development Manager. He has led the development of several commercially successful projects and has managed and coordinated fundamental programs at several universities and national laboratories. Dr. Daly has won several awards for this work including: Nortech Top 50 Industrial Innovation Award for Northeast Ohio; Recipient, R&D Magazine Top 100 Industrial Innovation Awards Recipient; and ACS Environmental Industrial Innovation Award.

Alan Dean, At-Large

Alan Dean is the Managing Partner of Fund Operations for Greer Capital Advisors. Mr. Dean brings to Greer Capital Advisors more than 20 years experience in all aspects of technology transfer, in both the non-profit and for-profit sectors.  Prior to joining GCA, Mr. Dean was Director of the University of Texas Health Science Center in San Antonio’s Office of Technology Transfer, where he played a prominent role in the formation of numerous successful technology companies, and in greatly elevating licensing productivity.  One of the defining and lucrative financial deals brought together the inventor of the original vascular stent, Dr. Julio Palmaz, the University, and Johnson & Johnson to further commercialize a new generation of stents and other implants.  Mr. Dean was also head of technology commercialization at Southern Research Institute, an institution known for its oncology drug discoveries, and led the team responsible for licensing Institute inventions and forming technology spin-offs.  He co-founded the drug-delivery company, Southern BioSystems, Inc., which was later acquired by a public company.  Mr. Dean has served in a director and advisory capacity on many corporate boards, a notable example being an advisor for GCA’s S.C.O.U.T. Fund.  He has had extensive experience and responsibility for financing the growth of technology companies, including private placements and industrial development bonds, and has served in all management capacities at one time or another for various start-ups.  Mr. Dean sits on the board of CardioSpectra, Inc., one of Scout Health Care Fund’s portfolio companies as well as BioDtech, one of the Birmingham Technology Fund’s portfolio companies.  Mr. Dean’s educational background includes an MBA from the UAB and a B.S. in Chemistry from the University of Alabama.

Board of Directors

Khursheed Anwer, Ph.D., Expression Genetics

Alane Barnes,  BioCryst Pharmaceuticals

Cecil Bostany, Warren, Averett, Kimbrough & Marino

Will Brooke, Harbert Venture Partners

Michael Chambers, Swift Biotech

James Childs,Bradley Arant Boult Cummings

Steve Ceulemans, Birmingham Business Alliance

Dan Daly, Ph.D., The University of Alabama

Alan Dean, Greer Capital

Ker Ferguson, Ph.D., The University of South Alabama

Jian Han, Ph.D.,  iRepertoire

Devon Laney, Innovation Depot

Richard Marchase, Ph.D., University of Alabama at Birmingham

Richard Myers, Ph.D., HudsonAlpha Institute of Biotechnology

Kathy Nugent, BioAlabama

Brian Pollock, Kalios Genetics

Gene Price, Burr & Forman LLP

Marshall Schreeder, Conversant Bio

Jack Secrist, Ph.D., Southern Research Institute

O’Neal Smitherman, Ph.D., HudsonAlpha Institute of Biotechnology

Jan Thornton, Auburn University

Art Tipton, Ph.D.,  Evonik Pharmaceuticals

Mike Walters, Kailos Genetics

Carter Wells, HudsonAlpha Institute of Biotechnology

Angela Wier,  Economics Development Partnership of Alabama

Dave Winwood, Ph.D., UAB Research Foundation